ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

ALTX Therapeutics Limited

ALTX Therapeutics Limited is an active company incorporated on 28 August 2025 with the registered office located in Huntingdon, Cambridgeshire. ALTX Therapeutics Limited was registered 3 months ago.
Status
Active
Active since incorporation
Company No
16677457
Private limited company
Age
3 months
Incorporated 28 August 2025
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Dated 27 August 2026
Due by 10 September 2026 (9 months remaining)
Accounts
Not Submitted
Awaiting first accounts
For period ending 31 March 2026
Due by 31 December 2026 (1 year remaining)
Address
Burnham House, Splash Lane
Wyton
Huntingdon
PE28 2AF
England
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
5
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Mar 1989
Director • British • Lives in UK • Born in Jun 1972
Director • British • Lives in UK • Born in Jul 1959
Director • Managing Partner • British • Lives in UK • Born in Aug 1963
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Slingshot Therapeutics Holdings Limited
Archangel Accounting Limited and Edward Eliot Hodgkin are mutual people.
Active
Slingshot Therapeutics Limited
Archangel Accounting Limited and Edward Eliot Hodgkin are mutual people.
Active
Mosaic Therapeutics Limited
Edward Eliot Hodgkin is a mutual person.
Active
Apini Therapeutics Limited
Archangel Accounting Limited is a mutual person.
Active
Yellowstone Biosciences Limited
Gonzalo Andres Garcia Gajardo is a mutual person.
Active
Syncona Ip Holdco (3) Limited
Gonzalo Andres Garcia Gajardo is a mutual person.
Active
Change Bio Ltd
Archangel Accounting Limited is a mutual person.
Active
Syncona Ip Holdco (4) Limited
Gonzalo Andres Garcia Gajardo is a mutual person.
Active
Financials
ALTX Therapeutics Limited has not yet submitted any accounts
Period Ended
Due Soon
Cash in Bank
Due Soon
Turnover
Due Soon
Employees
Due Soon
Total Assets
Due Soon
Total Liabilities
Due Soon
Net Assets
Due Soon
Debt Ratio (%)
Due Soon
Latest Activity
Simon Boulton (PSC) Resigned
1 Month Ago on 4 Nov 2025
Dr Simon Joseph Boulton Appointed
1 Month Ago on 4 Nov 2025
Dr David George Allen Appointed
1 Month Ago on 4 Nov 2025
Slingshot Therapeutics Holdings Limited (PSC) Appointed
1 Month Ago on 4 Nov 2025
Simon Boulton (PSC) Appointed
1 Month Ago on 20 Oct 2025
Slingshot Therapeutics Holdings Limited (PSC) Resigned
1 Month Ago on 20 Oct 2025
Archangel Accounting Limited Appointed
1 Month Ago on 20 Oct 2025
Accounting Period Shortened
3 Months Ago on 2 Sep 2025
Incorporated
3 Months Ago on 28 Aug 2025
Name changed from Slingshot Altco Limited
3 Months Ago on 28 Aug 2025
Get Credit Report
Discover ALTX Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Cessation of Simon Boulton as a person with significant control on 4 November 2025
Submitted on 27 Nov 2025
Appointment of Dr Simon Joseph Boulton as a director on 4 November 2025
Submitted on 27 Nov 2025
Appointment of Dr David George Allen as a director on 4 November 2025
Submitted on 25 Nov 2025
Notification of Slingshot Therapeutics Holdings Limited as a person with significant control on 4 November 2025
Submitted on 25 Nov 2025
Resolutions
Submitted on 25 Nov 2025
Memorandum and Articles of Association
Submitted on 25 Nov 2025
Statement of capital following an allotment of shares on 4 November 2025
Submitted on 21 Nov 2025
Certificate of change of name
Submitted on 19 Nov 2025
Notification of Simon Boulton as a person with significant control on 20 October 2025
Submitted on 23 Oct 2025
Statement of capital following an allotment of shares on 20 October 2025
Submitted on 23 Oct 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year